Clinical Trial Update: A Single Dose Safety, Tolerability, Pharmacokinetic and Food Effect Study of KVD900 (Sebetralstat) in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, pharmacokinetics and food effect of a single dose of KVD900 (Sebetralstat) in healthy volunteers has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• KVD900 (Sebetralstat)

Snippet

Sponsor: KalVista Pharmaceuticals, Ltd. | Conditions: Hereditary Angioedema | Phase 1 | Status: COMPLETED